Latest Breaking News On - Zahed subhan - Page 1 : comparemela.com

Adhera Therapeutics to Collaborate with Alberta Diabetes

Data will be instrumental in upcoming Phase 2 clinical trial of MLR-1023, Adhera’s novel Type 1 Diabetes drug candidateCompany moving forward with.

Zahed subhanJean buteauAndrew kucharchukExchange commissionUniversity of albertaAlberta diabetes institute is canadaAdhera therapeutics incAlberta diabetes instituteEdmonton protocolChief executive officerChief operating officerTypei diabetesNon alcoholic steatohepatitisFamilial adenomatous polyposisPrivate securities litigation reform actAdhera therapeutic

Adhera Therapeutics Appoints T - GuruFocus com

GuruFocus Article or News written by GuruFocusNews and the topic is about:

Zahed subhanTrondk waernessAndrew kucharchukRx sample solutionsCompany board of directorsAdhera therapeutics incRoyal norwegian armyLundy fetterman school of business at campbell universityExchange commissionBaton rougeCornerstone biopharmaJobson healthcareLundy fetterman schoolChief executive officerChief scientificMelior discovery

Adhera Therapeutics Appoints Trond K Waerness as Chairman of the Board, Company Focuses on Uplist to NASDAQ

Adhera Therapeutics Appoints Trond K Waerness as Chairman of the Board, Company Focuses on Uplist to NASDAQ
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Zahed subhanTrondk waernessAndrew kucharchukRx sample solutionsCompany board of directorsAdhera therapeutics incRoyal norwegian armyLundy fetterman school of business at campbell universityExchange commissionCornerstone biopharmaJobson healthcareLundy fetterman schoolChief executive officerChief scientificMelior discoveryNon alcoholic steatohepatitis